Not Medicare Enrolled

Dr. Alex De Jesus, MD

Rheumatology · San Antonio, TX
Speaking/Promotional
7959 FREDERICKSBURG RD, San Antonio, TX 78229
2103967410
In practice since 2006 (20 years)
NPI: 1013986629 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Jesus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Jesus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De Jesus

Dr. Alex De Jesus is a rheumatology specialist in San Antonio, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. De Jesus received a total of $180,051 from 32 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De Jesus is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $180,051 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$180,051
Total received (2018-2021)
Avg $45,013/year across 4 years
Top 5% in TX for rheumatology
32
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164,558 (91.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,341 (5.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,153 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$2,396
2020
$19,334
2019
$46,393
2018
$111,929

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$137,085
AbbVie, Inc.
$23,443
Janssen Biotech, Inc.
$10,398
AbbVie Inc.
$4,056
Horizon Therapeutics plc
$1,011
E.R. Squibb & Sons, L.L.C.
$719
Novartis Pharmaceuticals Corporation
$387
UCB, Inc.
$317
Mallinckrodt Hospital Products Inc.
$311
Amgen Inc.
$290
GENZYME CORPORATION
$260
Genentech USA, Inc.
$220
PFIZER INC.
$185
GlaxoSmithKline, LLC.
$180
Antares Pharma, Inc.
$178
Radius Health, Inc.
$144
Lilly USA, LLC
$138
Mallinckrodt LLC
$137
Horizon Pharma plc
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Pacira Therapeutics, Inc.
$91
Mallinckrodt Enterprises LLC
$51
AstraZeneca Pharmaceuticals LP
$39
MEDEXUS PHARMA, INC.
$33
MEDAC PHARMA, INC.
$31
SANOFI-AVENTIS U.S. LLC
$25
FIDIA PHARMA USA INC.
$18
Flexion Therapeutics, Inc.
$17
Organon LLC
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Bioventus LLC
$14
Ferring Pharmaceuticals Inc.
$12
Top 3 companies account for 94.9% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · COSENTYX · CUVITRU · Cimzia · Durolane · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · Hymovis · INFLECTRA · KEVZARA · KRYSTEXXA · OFEV · ORENCIA · OTREXUP · Otrexup · RAYOS · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · STELARA · SYNVISC-ONE · TALTZ · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for rheumatology in TX.

Looking for a rheumatology specialist in San Antonio?
Compare rheumatologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
50
Per 100K population
2.5
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2021
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. De Jesus is a rheumatology specialist, with speaking/promotional industry engagement in the top 5% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. De Jesus receive payments from pharmaceutical companies?
Yes. Dr. De Jesus received a total of $180,051 from 32 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. De Jesus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in San Antonio
Browse rheumatologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →